You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CML-AP

Showing 26 - 50 of 858
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

Recruiting
  • CML, Chronic Phase
  • Flumatinib mesylate tablets (400mg)
  • Flumatinib mesylate tablets (600mg)
  • Harbin, Hei Longjiang, China
    Institute of Hematology and Oncology, Harbin The First Hospital
Apr 28, 2022

Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

Recruiting
  • Leukemia, Chronic Myelogenous
  • Chongqing City, Chongqing, China
  • +23 more
Jan 18, 2023

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Chronic Myeloid Leukemia
      • Montréal, Quebec, Canada
      • +25 more
      Jul 25, 2022

      Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in China (Ponatinib)

      Recruiting
      • Chronic Myeloid Leukemia
      • Acute Lymphoblastic Leukemia
      • Hefei, Anhui, China
      • +13 more
      Aug 11, 2020

      CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

      Completed
      • Chronic Phase Chronic Myelogenous Leukemia
      • +3 more
        • Limerick, Dooradoyle, Ireland
        • +32 more
        Aug 13, 2021

        Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

        Active, not recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Beijing, China
          Peking University People's Hospital(北京大学人民医院)
        Jan 3, 2022

        Vascular Occlusive Events Associated With ICLUSIG®

        Terminated
        • Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
          • Hackensack, New Jersey
          • +1 more
          Oct 30, 2020

          Myeloid Leukemia, Chronic, Chronic Phase Trial in Worldwide (Ponatinib)

          Active, not recruiting
          Has Results
          • Myeloid Leukemia, Chronic, Chronic Phase
          • Atlanta, Georgia
          • +85 more
          Jan 4, 2022

          Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

          Terminated
          Has Results
          • Chronic Phase Chronic Myeloid Leukemia
          • Ponatinib 30 mg QD
          • +2 more
          • Bruxelles, Belgium
            Cliniques Universitaire Saint-Luc (Site 058)
          Oct 28, 2021

          Chronic Myelogenous Leukemia - Chronic Phase Trial in China (Dasatinib Tablets)

          Completed
          • Chronic Myelogenous Leukemia - Chronic Phase
          • Dasatinib Tablets
          • Shenzhen, Guangdong, China
          • +3 more
          Jun 11, 2021

          Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

          Active, not recruiting
          • Chronic Myelogenous Leukemia
          • Amman, Jordan
          • +4 more
          Jan 17, 2022

          Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

          Recruiting
          • Acute Myeloid Leukemia
          • +8 more
          • Ghent, Belgium
          • +28 more
          Nov 11, 2022

          Chronic Myeloid Leukemia, Chronic Phase Trial in Spain (Ponatinib 15 MG, Acetylsalicylic acid 100 MG)

          Recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
          • Ponatinib 15 MG
          • Acetylsalicylic acid 100 MG
          • L'Hospitalet De Llobregat, Barcelona, Spain
          • +12 more
          Feb 8, 2022

          Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

          Active, not recruiting
          Has Results
          • Chronic Myeloid Leukemia
          • Los Angeles, California
          • +61 more
          Mar 17, 2022

          Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

          Completed
          Has Results
          • Chronic Phase Chronic Myeloid Leukemia
          • Duarte, California
          • +27 more
          Dec 7, 2021

          CML, Imatinib Trial in Seoul (high-dose imatinib)

          Completed
          • CML
          • Imatinib
          • high-dose imatinib
          • Seoul, Korea, Republic of
            Novartis Investigational Site
          Mar 9, 2021

          Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +2 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jun 15, 2022

          Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

          Terminated
          • Accelerated Phase Chronic Myelogenous Leukemia (CML)
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Nov 17, 2020

          Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

          Active, not recruiting
          Has Results
          • Chronic Myelogenous Leukemia
          • Nilotinib followed by treatment-free
          • Fort Myers, Florida
          • +113 more
          Apr 25, 2022

          Concomitant Medications at CML Diagnosis

          Completed
          • Chronic Myeloid Leukemia
          • the prevalence of comorbid conditions
          • (no location specified)
          Sep 16, 2023

          Chronic Kidney Diseases, Hyperphosphatemia Trial in Chengdu (AP-306, Sevelamer Carbonate)

          Recruiting
          • Chronic Kidney Diseases
          • Hyperphosphatemia
          • Chengdu, Sichuan, China
            Sichuan Provincial People's Hospital
          Mar 9, 2023